logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Glenmark Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    532296
    INE935A01035
    848.5800097
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    GLENMARK
    17.15
    39519.04
    EPS(TTM)
    Face Value()
    Div & Yield %:
    81.65
    1
    0.18
     
G K Consultants standalone net profit rises 166.67% in the December 2024 quarter
Feb 15,2025
Net profit of G K Consultants rose 166.67% to Rs 0.08 crore in the quarter ended December 2024 as against Rs 0.03 crore during the previous quarter ended December 2023. Sales rose 7.14% to Rs 0.15 crore in the quarter ended December 2024 as against Rs 0.14 crore during the previous quarter ended December 2023.

ParticularsQuarter Ended
Dec. 2024Dec. 2023% Var.
Sales0.150.14 7
OPM %53.3321.43 -
PBDT0.080.03 167
PBT0.080.03 167
NP0.080.03 167